期刊
ANAEROBE
卷 60, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.anaerobe.2019.102092
关键词
Clostridioides difficile; Clostridium difficile; Fecal microbiota transplant; Recurrence
类别
资金
- US Department of Veterans Affairs Research Service
Despite lack of regulatory approval, fecal microbiota transplantation (FMT) is widely performed to manage C. difficile infection (CDI), particularly recurrent CDI. Herein, we critically review the available randomized controlled trials of FMT and address the following questions: Is FMT better than drug management of recurrent CDI?; Is FMT treatment per se or adjunctive treatment to antibiotics for CDI?; and, Is FMT safe? Finally, we elaborate non-FMT options for the management of recurrent CDI. Although promising, FMT should be reserved for patients who have failed appropriate antibiotic management of recurrent CDI. (C) 2019 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据